Ergoteles’s Enovis ENOV Stock Holding History

Ergoteles’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,906	Closed	-$1.44M	–	1157
2023 Q1	$1.44M	Buy	26,906 +5,025	+23%	+$291K	0.06%	368
2022 Q4	$1.17M	Buy	21,881 +6,805	+45%	+$351K	0.04%	414
2022 Q3	$695K	Buy	+15,076	New	+$817K	0.02%	640
2022 Q2	–	Sell	-31,241	Closed	-$2.14M	–	1734
2022 Q1	$2.14M	Buy	+31,241	New	+$2.23M	0.08%	248

Other funds holding ENOV

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Ergoteles's ENOV Position: Q2 2023 in Review

Ergoteles sold out of Enovis (ENOV) in Q2 2023, closing a stake of 26,906 shares — an estimated $1.44M sold.

Ergoteles first reported a position in ENOV in Q1 2022 and held it in 4 quarters. The position peaked at $2.14M in Q1 2022. 261 funds tracked by Wall St. Rank hold ENOV as of Q2 2023.

Ergoteles reported no remaining Enovis position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 26,906 Enovis shares in Q2 2023, an estimated $1.44M.
Ergoteles first reported a position in Enovis in Q1 2022 and held it in 4 quarters.
Ergoteles's Enovis position peaked at $2.14M in Q1 2022.
261 funds tracked by Wall St. Rank held Enovis as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.